Literature DB >> 22267196

Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy.

Giuseppe Sanguineti1, Francesco Ricchetti, Binbin Wu, Nishant Agrawal, Christine Gourin, Harold Agbahiwe, Shanthi Marur, Stefania Clemente, Todd McNutt, Arlene Forastiere.   

Abstract

BACKGROUND: To assess volumetric changes of human papillomavirus (HPV)-related lymph nodes (LN) before, during, and after a course of intensity-modulated radiation therapy (IMRT) ± chemotherapy.
METHODS: Each "pathologic" LN (≥1 cm) was contoured on the available diagnostic/planning CTs before, during each week, and after treatment.
RESULTS: Seventy-nine LNs in 50 patients were identified. Beyond the first week of treatment, 3 patterns of LN change were recorded: consistently shrinking LN (n = 33; 41.8%), inconsistently shrinking LN with temporary enlargement limited to the first week (n = 14; 17.7%), or also during the subsequent weeks (n = 32; 40.5%). Nodal density at planning is highly predictive of group assignment, with a larger mean density for consistently over inconsistently shrinking LNs (p = .009). Also, this grouping predicts the response at the end of treatment.
CONCLUSION: HPV-related LN behavior during IMRT is extremely variable but somewhat predictable on the basis of nodal density at planning.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22267196      PMCID: PMC3715074          DOI: 10.1002/hed.21981

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  27 in total

1.  Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.

Authors:  Sandro V Porceddu; David I Pryor; Elizabeth Burmeister; Bryan H Burmeister; Michael G Poulsen; Matthew C Foote; Benedict Panizza; Scott Coman; David McFarlane; William Coman
Journal:  Head Neck       Date:  2011-01-14       Impact factor: 3.147

Review 2.  Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?

Authors:  Phillip K Pellitteri; Alfio Ferlito; Alessandra Rinaldo; Jatin P Shah; Randal S Weber; John Lowry; Jesus E Medina; Christine G Gourin; K Thomas Robbins; Carlos Suárez; Ashok R Shaha; Eric M Genden; C René Leemans; Jean Louis Lefebvre; Luiz P Kowalski; William I Wei
Journal:  Head Neck       Date:  2006-02       Impact factor: 3.147

3.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

Authors:  Eric K Hansen; M Kara Bucci; Jeanne M Quivey; Vivian Weinberg; Ping Xia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-26       Impact factor: 7.038

4.  Prognostic value of the regression rate of neck node metastases during radiotherapy.

Authors:  H Bartelink
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

5.  Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes.

Authors:  J P Bataini; J Bernier; B Asselain; C Lave; C Jaulerry; F Brunin; D Pontvert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-04       Impact factor: 7.038

6.  Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma.

Authors:  Hiroya Ojiri; William M Mendenhall; Scott P Stringer; Patches L Johnson; Anthony A Mancuso
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

7.  Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer.

Authors:  J N Munck; E Cvitkovic; J D Piekarski; E Benhamou; G Recondo; M Bachouchi; E Tellez-Bernal; B Luboinski; F Eschwege; P Wibault
Journal:  J Natl Cancer Inst       Date:  1991-04-17       Impact factor: 13.506

8.  Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx.

Authors:  Andrew R Gordon; Laurie A Loevner; Amita Shukla-Dave; Regina O Redfern; Adina I Sonners; Alex M Kilger; Mark A Elliott; Mitchell Machtay; Randal S Weber; Jerry D Glickson; David I Rosenthal
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.

Authors:  Jerry L Barker; Adam S Garden; K Kian Ang; Jennifer C O'Daniel; He Wang; Laurence E Court; William H Morrison; David I Rosenthal; K S Clifford Chao; Susan L Tucker; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

10.  The regression of tumors of the head and neck treated with neutrons.

Authors:  E M Bessell; M Catterall
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-06       Impact factor: 7.038

View more
  8 in total

1.  Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Authors:  Mehdi Taghipour; Esther Mena; Matthew J Kruse; Sara Sheikhbahaei; Rathan M Subramaniam
Journal:  Nucl Med Commun       Date:  2017-03       Impact factor: 1.690

2.  Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.

Authors:  Chad Tang; Clifton D Fuller; Adam S Garden; Musaddiq J Awan; Rivka R Colen; William H Morrison; Steven J Frank; Beth M Beadle; Jack Phan; Erich M Sturgis; Mark E Zafereo; Randal S Weber; David I Rosenthal; G Brandon Gunn
Journal:  Oral Oncol       Date:  2014-11-28       Impact factor: 5.337

3.  Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.

Authors:  Adam S Garden; Gary B Gunn; Amy Hessel; Beth M Beadle; Salmaan Ahmed; Adel K El-Naggar; Clifton D Fuller; Lauren A Byers; Jack Phan; Steven J Frank; William H Morrison; Merill S Kies; David I Rosenthal; Erich M Sturgis
Journal:  Cancer       Date:  2014-06-04       Impact factor: 6.860

Review 4.  New insights into human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  P Boscolo-Rizzo; A Del Mistro; F Bussu; V Lupato; L Baboci; G Almadori; M C DA Mosto; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-04       Impact factor: 2.124

5.  Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Authors:  Anna Merlotti; Daniela Alterio; Riccardo Vigna-Taglianti; Alessandro Muraglia; Luciana Lastrucci; Roberto Manzo; Giuseppina Gambaro; Orietta Caspiani; Francesco Miccichè; Francesco Deodato; Stefano Pergolizzi; Pierfrancesco Franco; Renzo Corvò; Elvio G Russi; Giuseppe Sanguineti
Journal:  Radiat Oncol       Date:  2014-12-29       Impact factor: 3.481

6.  A convolutional neural network for contouring metastatic lymph nodes on diffusion-weighted magnetic resonance images for assessment of radiotherapy response.

Authors:  Oliver J Gurney-Champion; Jennifer P Kieselmann; Kee H Wong; Brian Ng-Cheng-Hin; Kevin Harrington; Uwe Oelfke
Journal:  Phys Imaging Radiat Oncol       Date:  2020-07

7.  MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

Authors:  S E J Connor; C Burd; N Sivarasan; V Goh
Journal:  Eur Radiol       Date:  2021-05-19       Impact factor: 5.315

8.  End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma.

Authors:  Whitney Sumner; Sangwoo S Kim; Lucas Vitzthum; Kevin Moore; Todd Atwood; James Murphy; Sayuri Miyauchi; Joseph A Califano; Loren K Mell; Arno J Mundt; Andrew B Sharabi
Journal:  Radiat Oncol       Date:  2021-08-09       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.